{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P16070",
      "entity_text" : "CD44",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P69208",
      "entity_text" : "HA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0971" ],
      "Cellular_component" : [ "go:GO:0009986" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "Our drug delivery strategy exploits the strong binding affinity between HA and CD44, and reflects the fact that cancer treatments targeting CD44 expressing CSCs often show better therapeutic effect than other treatments XREF_BIBR.",
  "reading_complete" : "2020-08-02T08:30:53Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:29:11Z",
  "trigger" : "affinity",
  "evidence" : [ "affinity between HA and CD44" ],
  "pmc_id" : "4402499",
  "score" : 0
}